1. Home
  2. ABCL vs COUR Comparison

ABCL vs COUR Comparison

Compare ABCL & COUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$5.97

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Coursera Inc.

COUR

Coursera Inc.

HOLD

Current Price

$5.37

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABCL
COUR
Founded
2012
2012
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
ABCL
COUR
Price
$5.97
$5.37
Analyst Decision
Strong Buy
Buy
Analyst Count
5
15
Target Price
$8.40
$10.53
AVG Volume (30 Days)
7.5M
7.3M
Earning Date
05-11-2026
04-23-2026
Dividend Yield
N/A
N/A
EPS Growth
10.91
39.22
EPS
N/A
N/A
Revenue
$75,128,000.00
$757,500,000.00
Revenue This Year
N/A
$9.43
Revenue Next Year
$21.85
$6.40
P/E Ratio
N/A
N/A
Revenue Growth
160.56
9.04
52 Week Low
$2.75
$5.00
52 Week High
$8.44
$13.56

Technical Indicators

Market Signals
Indicator
ABCL
COUR
Relative Strength Index (RSI) 44.40 41.40
Support Level $5.23 $5.11
Resistance Level $6.79 $5.51
Average True Range (ATR) 0.61 0.24
MACD -0.23 -0.04
Stochastic Oscillator 14.66 6.77

Price Performance

Historical Comparison
ABCL
COUR

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

About COUR Coursera Inc.

Coursera Inc is an online learning platform that connects learners, educators, and institutions with the goal of providing educational content that is affordable, accessible, and relevant. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The company operates through two reporting segments: Consumer and Enterprise. The majority of revenue is generated from the Consumer segment. The consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers.

Share on Social Networks: